Takai N, Ueda T, Nishida M, et al. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells[J]. Int J Mol Med, 2008, 21(1): 109-115.
[2]
Folkman J. Angiogenesis and apoptosis[J]. Cancer Biol, 2003, 13(2): 159-167.
[3]
[ 1 ] Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer[J]. Digestion, 2007, 76(1): 51-67.
[4]
[ 2 ] Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression[J]. Cancer Metastasis Rev, 2007, 26(3-4): 525-534.
[ 9 ] Chen Z, Zhang X, Li M, et al. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg-enase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck[J]. Clin Cancer Res, 2004, 10(17): 5930-5939.
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J]. Cancer Res, 2000, 60(5): 1306-1311.
[18]
Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis[J]. Neoplasia, 2001, 3(1): 53-61.
Suzuki O, Abe M. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma[J]. Oncol Rep, 2008, 19(3): 743-748.
